Solventum Corporation
SOLV
$66.07
-$1.46-2.16%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.25B | 8.22B | 8.21B | 8.20B | 8.20B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.25B | 8.22B | 8.21B | 8.20B | 8.20B |
| Cost of Revenue | 3.64B | 3.58B | 3.53B | 3.47B | 3.50B |
| Gross Profit | 4.61B | 4.63B | 4.68B | 4.73B | 4.69B |
| SG&A Expenses | 2.75B | 2.57B | 2.39B | 2.27B | 2.25B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.16B | 6.92B | 6.68B | 6.50B | 6.51B |
| Operating Income | 1.10B | 1.30B | 1.53B | 1.70B | 1.69B |
| Income Before Tax | 606.00M | 983.00M | 1.32B | 1.63B | 1.67B |
| Income Tax Expenses | 127.00M | 263.00M | 258.00M | 343.00M | 321.00M |
| Earnings from Continuing Operations | 479.00 | 720.00 | 1.06K | 1.29K | 1.35K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 479.00M | 720.00M | 1.06B | 1.29B | 1.35B |
| EBIT | 1.10B | 1.30B | 1.53B | 1.70B | 1.69B |
| EBITDA | 1.65B | 1.84B | 2.09B | 2.26B | 2.25B |
| EPS Basic | 2.77 | 4.16 | 6.12 | 7.47 | 7.79 |
| Normalized Basic EPS | 2.41 | 3.55 | 4.76 | 5.91 | 6.03 |
| EPS Diluted | 2.76 | 4.15 | 6.11 | 7.46 | 7.79 |
| Normalized Diluted EPS | 2.41 | 3.55 | 4.76 | 5.91 | 6.03 |
| Average Basic Shares Outstanding | 692.70M | 692.00M | 691.30M | 690.80M | 690.80M |
| Average Diluted Shares Outstanding | 694.60M | 692.80M | 691.60M | 690.80M | 690.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |